Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01158261 · ClinicalTrials.gov registry record
The Evicel Post-Authorization Surveillance Study
A clinical trial, sponsored by Ethicon.
- Completed
- Registry status
- 300
- Enrollment target
NCT01158261 is a clinical trial that has completed, run by Ethicon. The registered enrollment target is 300 participants.
The verdict
NCT01158261 has completed, sponsored by Ethicon.
- COMPLETED
- Registry status
- 300 participants
- Enrollment target
Study Summary
The objective of this non-interventional Post Authorisation Safety Surveillance (PASS) study is to observe the clinical safety performance of EVICEL when used as suture support for haemostasis in vascular surgery.
Interventions
- BIOLOGICAL EVICEL ™ Fibrin Sealant (Human)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2010-06 |
| Est. Completion | 2014-05 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01158261
The ClinicalTrials.gov registry entry for NCT01158261 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 300 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ethicon, which has 38 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which EVICEL ™ Fibrin Sealant (Human) is the first listed.
NCT01158261 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01158261 about?
NCT01158261 is a clinical study titled "The Evicel Post-Authorization Surveillance Study". The objective of this non-interventional Post Authorisation Safety Surveillance (PASS) study is to observe the clinical safety performance of EVICEL when used as suture support for haemostasis in vascular surgery.
What is the current status of trial NCT01158261?
This trial is currently completed. The enrollment target is 300 participants. The study started on 2010-06. Estimated completion is 2014-05.
What interventions are being tested in trial NCT01158261?
The interventions under investigation include: EVICEL ™ Fibrin Sealant (Human) (BIOLOGICAL).
Who is sponsoring clinical trial NCT01158261?
This trial is sponsored by Ethicon, which has 38 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.